VivoSim Labs, Inc. (VIVS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VivoSim Labs, Inc. on August 6, 2026. The filing addresses the Company's compliance with Nasdaq listing requirements and provides preliminary financial updates regarding liquidity and future revenue expectations.
Key Financial Metrics
- Liquidity: Preliminary cash on hand as of August 3, 2026, was approximately $10.1 million.
- Stockholders' Equity: The Company confirmed compliance with Nasdaq Listing Rule 5550(b)(1), maintaining a minimum stockholders' equity balance of $2.5 million.
- Revenue, Profit, and Margins: The filing text does not provide specific values for current revenue, profit, cash flow, or margins.
- Debt: The filing text does not provide specific values for outstanding debt.
Material Changes and Outlook
- Nasdaq Compliance: The Listing Qualifications Staff of The Nasdaq Stock Market LLC determined that the Company currently complies with the minimum stockholders' equity requirement.
- Revenue Guidance: Management anticipates revenue growth of 500% or more in fiscal year 2027.
- Management Commentary: The financial information presented is preliminary, based on current estimates, and subject to change due to financial closing procedures and final adjustments.
Investor Verification Checklist
- Verify the final audited cash balance as of the most recent quarter end to confirm the $10.1 million preliminary figure.
- Review the full press release (Exhibit 99.1) for details on the drivers behind the anticipated 500%+ revenue growth in FY2027.
- Confirm the Company's ongoing compliance with other Nasdaq listing standards beyond stockholders' equity.
- Monitor upcoming quarterly filings for finalized revenue and profitability metrics to validate management's growth projections.